vs

Side-by-side financial comparison of HomeTrust Bancshares, Inc. (HTB) and MEDIFAST INC (MED). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $53.6M, roughly 1.4× HomeTrust Bancshares, Inc.). On growth, HomeTrust Bancshares, Inc. posted the faster year-over-year revenue change (3.7% vs -36.9%). HomeTrust Bancshares, Inc. produced more free cash flow last quarter ($45.3M vs $-6.6M). Over the past eight quarters, HomeTrust Bancshares, Inc.'s revenue compounded faster (3.5% CAGR vs -34.4%).

HomeTrust Bancshares Inc. is an Asheville, North Carolina–based bank holding company with $4.3 billion in assets and 33 branches in North and South Carolina, Georgia and Tennessee. It is the parent of seven community banks—HomeTrust Bank, Tryon Federal Bank, Shelby Savings Bank, Home Savings Bank, Industrial Federal Bank, Cherryville Federal Bank and Rutherford County Bank.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

HTB vs MED — Head-to-Head

Bigger by revenue
MED
MED
1.4× larger
MED
$75.1M
$53.6M
HTB
Growing faster (revenue YoY)
HTB
HTB
+40.6% gap
HTB
3.7%
-36.9%
MED
More free cash flow
HTB
HTB
$52.0M more FCF
HTB
$45.3M
$-6.6M
MED
Faster 2-yr revenue CAGR
HTB
HTB
Annualised
HTB
3.5%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HTB
HTB
MED
MED
Revenue
$53.6M
$75.1M
Net Profit
Gross Margin
69.4%
Operating Margin
37.0%
-10.4%
Net Margin
Revenue YoY
3.7%
-36.9%
Net Profit YoY
EPS (diluted)
$0.93
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HTB
HTB
MED
MED
Q4 25
$53.6M
$75.1M
Q3 25
$54.1M
$89.4M
Q2 25
$54.4M
$105.6M
Q1 25
$50.9M
$115.7M
Q4 24
$51.7M
$119.0M
Q3 24
$50.6M
$140.2M
Q2 24
$50.6M
$168.6M
Q1 24
$50.0M
$174.7M
Net Profit
HTB
HTB
MED
MED
Q4 25
Q3 25
$16.5M
$-2.3M
Q2 25
$17.2M
$2.5M
Q1 25
$14.5M
$-772.0K
Q4 24
Q3 24
$13.1M
$1.1M
Q2 24
$12.4M
$-8.2M
Q1 24
$15.1M
$8.3M
Gross Margin
HTB
HTB
MED
MED
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
HTB
HTB
MED
MED
Q4 25
37.0%
-10.4%
Q3 25
38.5%
-4.6%
Q2 25
40.1%
-1.0%
Q1 25
36.2%
-1.1%
Q4 24
35.4%
0.6%
Q3 24
33.2%
1.5%
Q2 24
31.3%
-4.7%
Q1 24
38.0%
4.5%
Net Margin
HTB
HTB
MED
MED
Q4 25
Q3 25
30.5%
-2.5%
Q2 25
31.6%
2.3%
Q1 25
28.5%
-0.7%
Q4 24
Q3 24
25.9%
0.8%
Q2 24
24.6%
-4.8%
Q1 24
30.1%
4.8%
EPS (diluted)
HTB
HTB
MED
MED
Q4 25
$0.93
$-1.64
Q3 25
$0.95
$-0.21
Q2 25
$1.00
$0.22
Q1 25
$0.84
$-0.07
Q4 24
$0.83
$0.08
Q3 24
$0.76
$0.10
Q2 24
$0.73
$-0.75
Q1 24
$0.88
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HTB
HTB
MED
MED
Cash + ST InvestmentsLiquidity on hand
$324.7M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$600.7M
$198.9M
Total Assets
$4.5B
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HTB
HTB
MED
MED
Q4 25
$324.7M
$167.3M
Q3 25
$315.8M
$173.5M
Q2 25
$297.2M
$162.7M
Q1 25
$299.8M
$164.6M
Q4 24
$279.2M
$162.3M
Q3 24
$293.5M
$170.0M
Q2 24
$294.2M
$163.5M
Q1 24
$380.5M
$156.4M
Stockholders' Equity
HTB
HTB
MED
MED
Q4 25
$600.7M
$198.9M
Q3 25
$595.8M
$214.7M
Q2 25
$579.3M
$216.0M
Q1 25
$565.4M
$211.0M
Q4 24
$551.8M
$210.1M
Q3 24
$540.0M
$207.3M
Q2 24
$523.6M
$205.3M
Q1 24
$513.2M
$211.0M
Total Assets
HTB
HTB
MED
MED
Q4 25
$4.5B
$248.0M
Q3 25
$4.6B
$268.2M
Q2 25
$4.6B
$269.3M
Q1 25
$4.6B
$280.0M
Q4 24
$4.6B
$284.2M
Q3 24
$4.6B
$291.2M
Q2 24
$4.7B
$293.5M
Q1 24
$4.7B
$302.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HTB
HTB
MED
MED
Operating Cash FlowLast quarter
$49.5M
$-5.3M
Free Cash FlowOCF − Capex
$45.3M
$-6.6M
FCF MarginFCF / Revenue
84.5%
-8.8%
Capex IntensityCapex / Revenue
7.8%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$93.8M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HTB
HTB
MED
MED
Q4 25
$49.5M
$-5.3M
Q3 25
$-11.3M
$12.1M
Q2 25
$-8.8M
$-3.4M
Q1 25
$71.7M
$3.4M
Q4 24
$45.4M
$-4.9M
Q3 24
$43.8M
$9.1M
Q2 24
$5.9M
$13.1M
Q1 24
$-9.0M
$7.3M
Free Cash Flow
HTB
HTB
MED
MED
Q4 25
$45.3M
$-6.6M
Q3 25
$-12.0M
$10.8M
Q2 25
$-10.2M
$-4.8M
Q1 25
$70.7M
$1.9M
Q4 24
$42.4M
$-7.2M
Q3 24
$43.1M
$7.7M
Q2 24
$5.7M
$11.1M
Q1 24
$-9.6M
$5.4M
FCF Margin
HTB
HTB
MED
MED
Q4 25
84.5%
-8.8%
Q3 25
-22.2%
12.0%
Q2 25
-18.7%
-4.5%
Q1 25
138.7%
1.6%
Q4 24
82.0%
-6.1%
Q3 24
85.1%
5.5%
Q2 24
11.2%
6.6%
Q1 24
-19.2%
3.1%
Capex Intensity
HTB
HTB
MED
MED
Q4 25
7.8%
1.8%
Q3 25
1.4%
1.5%
Q2 25
2.5%
1.3%
Q1 25
2.0%
1.3%
Q4 24
5.9%
1.9%
Q3 24
1.3%
1.0%
Q2 24
0.5%
1.1%
Q1 24
1.1%
1.1%
Cash Conversion
HTB
HTB
MED
MED
Q4 25
Q3 25
-0.68×
Q2 25
-0.51×
-1.36×
Q1 25
4.93×
Q4 24
Q3 24
3.34×
8.04×
Q2 24
0.48×
Q1 24
-0.60×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons